NCT04083599 2026-03-16
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Genmab
Phase 1/2 Active not recruiting
Genmab
Eli Lilly and Company
Genfleet Therapeutics (Shanghai) Inc.
ImmunityBio, Inc.
Actuate Therapeutics Inc.
M.D. Anderson Cancer Center